The birth of ‘Dolly the sheep’ (the first animal to be cloned from an adult (somatic) cell) on 5th July 1996 marked a seminal moment in the field of developmental genetics for several reasons. It first provided unequivocal evidence of genomic equivalence between embryonic and somatic cells by demonstrating that it is possible to re-establish a pluripotent state in differentiated cells. In so doing, it inspired others to later identify at least some of the factors required for the induction of pluripotency in cultured somatic cells leading to the creation of ‘induced’ pluripotent stem cells (iPSCs) for therapeutic applications in both human and animal medicine (Takahashi & Yamanaka 2006). However, it was the need to develop an effective method by which to produce genetically modified (GM) livestock that drove the programme of work that ultimately led to the birth of Dolly. Existing GM approaches at that time relied on techniques, such as pronuclear DNA microinjection. These techniques were both inefficient and limited in their ability to introduce genetic change in large animals. Furthermore, in contrast to mice (Evans & Kaufman 1981, Martin 1981), the derivation and establishment of germ-line competent embryonic-stem cells (so amenable for introducing genetic modification in that species) has thus far remained elusive in livestock species. Thus, the approach adopted by Wilmut et al. (1997) involved the transfer of nuclei from somatic (i.e. cultured mammary) cells to enucleated oocytes followed by electrofusion and activation; a procedure referred to as somatic-cell nuclear transfer (SCNT).
The success of Dolly led quickly to a succession of papers reporting the birth of GM livestock derived from genetically altered somatic cells (e.g. Schnieke et al. 1997, Cibelli et al. 1998, Dai et al. 2002). However, both ethical and biological concerns regarding the underlying cloning procedure were raised at the time. Biological concerns related to the overall efficiency of SCNT, in utero and perinatal losses, together with the ‘biological’ age, longevity and health of cloned offspring; all of which threatened the prospect of generating GM animals by this means. In utero losses, developmental abnormalities and neonatal morbidity were attributable, at least in part, to the culture of gametes and embryos, which contribute independently to epigenetic dysregulation at both imprinted and non-imprinted loci (Young et al. 2001, Chen et al. 2017), leading to a phenomenon known as the large offspring syndrome (Young et al. 1998). Concerns were raised specifically about the health of Dolly, as she was diagnosed with osteoarthritis (OA) of the left stifle at a relatively young (5½ years) age (Rhind et al. 2004). It was suggested that she might have aged prematurely, and terminal fragment restriction analyses of her genomic DNA appeared to support the concept of telomere shortening (Shiels et al. 1999). However, this observation was at odds with those from other SCNT studies which generally found telomeres to ‘rejuvenate’ during nuclear reprogramming (Marión & Blasco 2010). Furthermore, our own retrospective radiographic assessments of the skeletons of Dolly, Megan and Morag (the latter two sheep had been cloned previously from differentiated cells; Campbell et al. 1996) reported a prevalence and severity of OA no different to that of naturally conceived sheep of comparable age (Corr et al. 2017). Indeed, several studies over the years have concluded that cloned offspring which survive beyond the neonatal period are healthy, age normally, produce viable offspring and animal products safe for human consumption (Lanza et al. 2001, Yang et al. 2007, Watanabe 2013, Sinclair et al. 2016). Yet concerns relating to animal welfare remain, and these have been sufficient to enforce a ban on commercial farm-animal cloning within the UK and EU, although not within the US and many other countries.
The consequence of this ban is that, in an era of comparatively well-funded iPSC research, the ability to undertake studies to improve the overall efficiency, safety and application of SCNT has been impeded. Yet, despite the global investment in iPSC research over the last 20 years, its potential for cell-based therapy has yet to be realised (Yamanaka 2020). Other commentators emphasise the merits of zygotic genome editing, using designer nucleases such as CRISPR/Cas9, to generate GM livestock, thus obviating the need for the more technically demanding SCNT (Tan et al. 2016). However, embryo mosaicism and low and variable germ-line transmission present challenges with this approach, particularly when multiplexed gene editing is required (Tanihara et al. 2021). Therefore, 25 years on, this anniversary issue of Reproduction addresses the question: is there still a role for SCNT in reproductive and regenerative medicine? It also considers how our understanding of the molecular mechanisms that underlie pregnancy failure and neonatal loss has improved over the past 25 years, describing refinements to procedures that impact on the overall efficiency of SCNT, whilst discussing residual ethical and societal concerns related to use of advanced reproductive technologies in animals and humans.
The issue (Video 1) opens with a brief historical perspective of the scientific legacy of Dolly from one of the co-authors (Prof Dr Angelika Schnieke) of the article that first reported this development in 1997. Klinger & Schnieke (2021) summarise current applications of SCNT and discuss its relevance in the 21st century. There then follows two articles that each provide both a historical and contemporary perspective on the role of SCNT in the generation of GM livestock. The first article (Polejaeva 2021) provides a detailed overview of the technical advances made in GM technologies over the past 25 years from a leading member of the team that produced the first cloned pigs by SCNT in 2000. This article also offers a perspective on the current and future role of SCNT in the creation of genetically engineered animals; a perspective that is extended by Galli & Lazzari (2021) who consider applications in several large-animal species together with intellectual-property and regulatory challenges that will ultimately determine its use.
The anniversary issue next considers the science underpinning SCNT. The establishment of a pluripotent state following nuclear transfer requires significant remodelling of inherited chromatin to occur within a matter of hours following reconstruction. These aspects are discussed for both farm and companion animals (Loi et al. 2021), and mice (Ogura et al. 2021), with emphasis placed on epigenetic modifications to chromatin required to induce a pluripotent state. Consideration is also given to the molecular events involved in chromatin remodelling in male and female gametes in the lead-up to syngamy during natural conception. It is based on the premise that a better understanding of these processes may lead to innovative approaches that will improve the overall efficiency of nuclear reprogramming.
The penultimate article in this series (Alberio & Wolf 2021) returns to the topic of GM livestock, considering further applications in animal breeding and the development of large-animal models for early human development and disease. The prospect of generating embryonic stem cells in farm animals may obviate the need for somatic cells and improve the overall efficiency of GM-livestock production, superseding current zygotic genome-editing approaches. The transfer of nuclei from such cells, rather than the creation of chimeric embryos, could then emerge to become the most effective means by which to establish GM-founder stock.
Finally, reference was made earlier in this editorial to ethical concerns raised following the birth of Dolly in 1996. The concluding article in this anniversary edition considers these issues and proposes that many of the concerns raised at that time persist to this day, although the context has somewhat shifted towards the use of genetic technologies that influence inheritance in both humans and farm animals (Greenfield 2021). The point is made that scientific and political judgements of what might be in the public interest may not necessarily be what the public wants or would choose. At the very least, it would seem that some 25 years later, the debate around the safe and ethical use of advanced reproductive technologies in human medicine and livestock production is ‘…still goin’ strong’.
Declaration of interest
The author declares that there is no conflict of interest that could be perceived as prejudicing the impartiality of this editorial.
Funding
This research did not receive any specific grant from any funding agency in the public, commercial or not-for-profit sector.
Acknowledgements
Article title derived from ‘Hello Dolly’: Jerry Herman.
References
Alberio R & Wolf E 2021 25th Anniversary of cloning by somatic-cell nuclear transfer: Nuclear transfer and the development of genetically modified/ gene edited livestock. Reproduction F59−F68.(https://doi.org/10.1530/REP-21-0078)
Campbell KH, McWhir J, Ritchie WA & Wilmut I 1996 Sheep cloned by nuclear transfer from a cultured cell line. Nature 380 64–66. (https://doi.org/10.1038/380064a0)
Chen Z, Hagen DE, Ji T, Elsik CG & Rivera RM 2017 Global misregulation of genes largely uncoupled to DNA methylome epimutations characterizes a congenital overgrowth syndrome. Scientific Reports 7 12667. (https://doi.org/10.1038/s41598-017-13012-z)
Cibelli JB, Stice SL, Golueke PJ, Kane JJ, Jerry J, Blackwell C, Ponce de León FA & Robl JM 1998 Cloned transgenic calves produced from nonquiescent fetal fibroblasts. Science 280 1256–1258. (https://doi.org/10.1126/science.280.5367.1256)
Corr SA, Gardner DS, Langley-Hobbs S, Ness MG, Kitchener AC & Sinclair KD 2017 Radiographic assessment of the skeletons of Dolly and other clones finds no abnormal osteoarthritis. Scientific Reports 7 15685. (https://doi.org/10.1038/s41598-017-15902-8)
Dai Y, Vaught TD, Boone J, Chen SH, Phelps CJ, Ball S, Monahan JA, Jobst PM, McCreath KJ, Lamborn AE et al. 2002 Targeted disruption of the alpha1,3-galactosyltransferase gene in cloned pigs. Nature Biotechnology 20 251–255. (https://doi.org/10.1038/nbt0302-251)
Evans MJ & Kaufman MH 1981 Establishment in culture of pluripotential cells from mouse embryos. Nature 292 154–156. (https://doi.org/10.1038/292154a0)
Galli C & Lazzari G 2021 Current applications of SCNT in advanced breeding and genome editing in livestock. Reproduction 162 [In press]. (https://doi.org/10.1530/REP-21-0006)
Greenfield A 2021 25th anniversary of cloning by somatic-cell nuclear transfer: Cloning, mitochondrial replacement and genome editing: 25 years of ethical debate since Dolly. Reproduction 162 F69− F78. (https://doi.org/10.1530/REP-20-0635)
Klinger B & Schnieke A 2021 25th Anniversary of cloning by somatic-cell nuclear transfer: twenty-five years after Dolly: how far have we come? Reproduction 162 F1− F10. (https://doi.org/10.1530/REP-20-0652)
Lanza RP, Cibelli JB, Faber D, Sweeney RW, Henderson B, Nevala W, West MD & Wettstein PJ 2001 Cloned cattle can be healthy and normal. Science 294 1893–1894. (https://doi.org/10.1126/science.1063440)
Loi P, Palazzese L, Scapalo PA, Fulka J Jr, Fulka H & Czernik M 2021 25th Anniversary of cloning by somatic-cell nuclear transfer: Scientific and technological approaches to improve SCNT efficiency in farm animals and pets. Reproduction 162 F33− F43. (https://doi.org/10.1530/REP-20-0653)
Marión RM & Blasco MA 2010 Telomere rejuvenation during nuclear reprogramming. Current Opinion in Genetics and Development 20 190–196. (https://doi.org/10.1016/j.gde.2010.01.005).
Martin GR 1981 Isolation of a pluripotent cell line from early mouse embryos cultured in medium conditioned by teratocarcinoma stem cells. PNAS 78 7634–7638. (https://doi.org/10.1073/pnas.78.12.7634)
Ogura A, Matoba S & Inoue K 2021 25th Anniversary of cloning by somatic-cell nuclear transfer: Epigenetic abnormalities associated with somatic cell nuclear transfer. Reproduction 162 F45− F58. (https://doi.org/10.1530/REP-21-0013)
Polejaeva IA 2021 25th Anniversary of cloning by somatic-cell nuclear transfer: Generation of genetically engineered livestock using somatic cell nuclear transfer. Reproduction 162 F11− F22. (https://doi.org/10.1530/REP-21-0072)
Rhind S, Cui W, King T, Ritchie W, Wylie D & Wilmut I 2004 69 Dolly: a final report. Reproduction, Fertility and Development 16 156. (https://doi.org/10.1071/RDv16n1Ab69)
Schnieke AE, Kind AJ, Ritchie WA, Mycock K, Scott AR, Ritchie M, Wilmut I, Colman A & Campbell KH 1997 Human factor IX transgenic sheep produced by transfer of nuclei from transfected fetal fibroblasts. Science 278 2130–2133. (https://doi.org/10.1126/science.278.5346.2130)
Shiels PG, Kind AJ, Campbell KH, Waddington D, Wilmut I, Colman A & Schnieke AE 1999 Analysis of telomere lengths in cloned sheep. Nature 399 316–317. (https://doi.org/10.1038/20580).
Sinclair KD, Corr SA, Gutierrez CG, Fisher PA, Lee JH, Rathbone AJ, Choi I, Campbell KH & Gardner DS 2016 Healthy ageing of cloned sheep. Nature Communications 7 12359. (https://doi.org/10.1038/ncomms12359)
Takahashi K & Yamanaka S 2006 Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors. Cell 126 663–676. (https://doi.org/10.1016/j.cell.2006.07.024)
Tan W, Proudfoot C, Lillico SG & Whitelaw CB 2016 Gene targeting, genome editing: from Dolly to editors. Transgenic Research 25 273–287. (https://doi.org/10.1007/s11248-016-9932-x)
Tanihara F, Hirata M, Nguyen NT, Sawamoto O, Kikuchi T & Otoi T 2021 One-step generation of multiple gene-edited pigs by electroporation of the CRISPR/Cas9 system into zygotes to reduce xenoantigen biosynthesis. International Journal of Molecular Sciences 22 2249. (https://doi.org/10.3390/ijms22052249)
Watanabe S 2013 Effect of calf death loss on cloned cattle herd derived from somatic cell nuclear transfer: clones with congenital defects would be removed by the death loss. Animal Science Journal 84 631–638. (https://doi.org/10.1111/asj.12087)
Wilmut I, Schnieke AE, McWhir J, Kind AJ & Campbell KH 1997 Viable offspring derived from fetal and adult mammalian cells. Nature 385 810–813. (https://doi.org/10.1038/385810a0)
Yamanaka S 2020 Pluripotent stem cell-based cell therapy-promise and challenges. Cell Stem Cell 27 523–531. (https://doi.org/10.1016/j.stem.2020.09.014)
Yang X, Tian XC, Kubota C, Page R, Xu J, Cibelli J & Seidel G Jr 2007 Risk assessment of meat and milk from cloned animals. Nature Biotechnology 25 77–83. (https://doi.org/10.1038/nbt1276)
Young LE, Sinclair KD & Wilmut I 1998 Large offspring syndrome in cattle and sheep. Reviews of Reproduction 3 155–163. (https://doi.org/10.1530/ror.0.0030155)
Young LE, Fernandes K, McEvoy TG, Butterwith SC, Gutierrez CG, Carolan C, Broadbent PJ, Robinson JJ, Wilmut I & Sinclair KD 2001 Epigenetic change in IGF2R is associated with fetal overgrowth after sheep embryo culture. Nature Genetics 27 153–154. (https://doi.org/10.1038/84769)